212 related articles for article (PubMed ID: 18076206)
1. The therapeutic potential of VEGF inhibition in diabetic microvascular complications.
Tremolada G; Lattanzio R; Mazzolari G; Zerbini G
Am J Cardiovasc Drugs; 2007; 7(6):393-8. PubMed ID: 18076206
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous microangiopathy in patients with type 2 diabetes: Impaired vascular endothelial growth factor expression and its correlation with neuropathy, retinopathy and nephropathy.
Sugimoto K; Murakami H; Deguchi T; Arimura A; Daimon M; Suzuki S; Shimbo T; Yagihashi S
J Diabetes Investig; 2019 Sep; 10(5):1318-1331. PubMed ID: 30719863
[TBL] [Abstract][Full Text] [Related]
3. How to prevent the microvascular complications of type 2 diabetes beyond glucose control.
Valencia WM; Florez H
BMJ; 2017 Jan; 356():i6505. PubMed ID: 28096078
[TBL] [Abstract][Full Text] [Related]
4. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.
Happich M; Breitscheidel L; Meisinger C; Ulbig M; Falkenstein P; Benter U; Watkins J
Curr Med Res Opin; 2007 Jun; 23(6):1367-74. PubMed ID: 17559744
[TBL] [Abstract][Full Text] [Related]
5. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.
Emerson MV; Lauer AK
BioDrugs; 2007; 21(4):245-57. PubMed ID: 17628122
[TBL] [Abstract][Full Text] [Related]
6. Diabetic retinopathy, nephropathy and neuropathy. Generalized vascular damage in insulin-dependent diabetic patients.
Jensen T; Deckert T
Horm Metab Res Suppl; 1992; 26():68-70. PubMed ID: 1490695
[TBL] [Abstract][Full Text] [Related]
7. Effects of sarpogrelate on microvascular complications with type 2 diabetes.
Yoo H; Park I; Kim DJ; Lee S
Int J Clin Pharm; 2019 Apr; 41(2):563-573. PubMed ID: 30864083
[TBL] [Abstract][Full Text] [Related]
8. A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy?
Williams B
Miner Electrolyte Metab; 1998; 24(6):400-5. PubMed ID: 9930379
[TBL] [Abstract][Full Text] [Related]
9. Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes.
Kaabi YA
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364178
[TBL] [Abstract][Full Text] [Related]
10. [Causes and treatment of diabetic complications].
Sakamoto N
Nihon Naika Gakkai Zasshi; 1989 Nov; 78(11):1540-3. PubMed ID: 2693554
[No Abstract] [Full Text] [Related]
11. [Role of PKC in the pathogenesis of diabetic vascular complications].
Inoguchi T; Umeda F
Nihon Rinsho; 2002 Oct; 60 Suppl 10():67-72. PubMed ID: 12430209
[No Abstract] [Full Text] [Related]
12. Intrarenal arterial resistance is associated with microvascular complications in Chinese type 2 diabetic patients.
Liu KH; Chu WC; Kong AP; Ko GT; Ma RC; Chan JW; So WY; Luk AO; Cheung KK; Ozaki R; Ahuja AT; Chan JC
Nephrol Dial Transplant; 2013 Mar; 28(3):651-8. PubMed ID: 23223219
[TBL] [Abstract][Full Text] [Related]
13. Visual functioning and health-related quality of life in diabetic patients about to undergo anti-vascular endothelial growth factor treatment for sight-threatening macular edema.
Granström T; Forsman H; Leksell J; Jani S; Raghib AM; Granstam E
J Diabetes Complications; 2015; 29(8):1183-90. PubMed ID: 26318959
[TBL] [Abstract][Full Text] [Related]
14. Ruboxistaurin.
Taulien CA; Joy SV
Drugs Today (Barc); 2006 Sep; 42(9):577-85. PubMed ID: 17028667
[TBL] [Abstract][Full Text] [Related]
15. Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.
Bilous R
Prim Care Diabetes; 2008 Dec; 2(4):201-2. PubMed ID: 18760685
[No Abstract] [Full Text] [Related]
16. Molecule of the month. Ruboxistaurin mesilate hydrate.
Drug News Perspect; 2003 Dec; 16(10):691. PubMed ID: 14747848
[No Abstract] [Full Text] [Related]
17. Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?
Boel E; Selmer J; Flodgaard HJ; Jensen T
J Diabetes Complications; 1995; 9(2):104-29. PubMed ID: 7599349
[TBL] [Abstract][Full Text] [Related]
18. The role of protein kinase C activation and the vascular complications of diabetes.
Das Evcimen N; King GL
Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
[TBL] [Abstract][Full Text] [Related]
19. [Diabetic complication: definition and classification].
Nishizawa Y
Nihon Rinsho; 1991 Feb; 49 Suppl():3-8. PubMed ID: 2033818
[No Abstract] [Full Text] [Related]
20. Relationship between increased left atrial volume and microvascular complications in patients with type 2 diabetes.
Bonapace S; Rossi A; Lipari P; Bertolini L; Zenari L; Lanzoni L; Canali G; Molon G; Mantovani A; Zoppini G; Bonora E; Barbieri E; Targher G
J Diabetes Complications; 2015 Aug; 29(6):822-8. PubMed ID: 26050564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
